NCT02560779 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02560779
Title	Trial of TRC105 and Sorafenib in Patients With HCC
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Tracon Pharmaceuticals Inc.
Indications	hepatocellular carcinoma
Therapies	Carotuximab + Sorafenib
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	City	State	Zip	Country	Details
MD Anderson	Houston	Texas	77030-4009	United States	Details
University Hospitals	Cleveland	Ohio	44106	United States	Details
University of Alabama	Birmingham	Alabama	35294-3300	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02560779Clinical Trial Detail